AI-Designed Gasdermins Programmed to Destroy Virus-Infected Cells

A new perspective published in Cell Research examines an ambitious frontier at the intersection of computational protein design and innate immunity: the deliberate engineering of gasdermin proteins, the pore-forming executioners of pyroptotic cell death, so that they can be directed with precision against cells harboring viral infection. The work, published under the title Programmed to kill: AI-guided gasdermins eliminate virus-infected cells, arrives at a moment when artificial intelligence tools for protein structure prediction and de novo design have matured from academic curiosities into practical instruments for building molecules that nature never produced. The convergence of these two streams—decades of mechanistic work on inflammatory cell death and the recent explosion in AI-driven protein engineering—raises the prospect of programmable killing machines that operate not by blocking viruses directly, but by eliminating the cellular factories in which they replicate.

Gasdermins occupy a unique position in the architecture of innate immunity. The family, which in humans includes GSDMA, GSDMB, GSDMC, GSDMD and GSDME, shares a common operational logic. Each protein consists of a cytotoxic N-terminal domain tethered to a C-terminal domain that acts as an internal restraint. In the resting state, the two domains bind each other so that the pore-forming capacity of the N-terminus is masked. When pattern-recognition receptors detect pathogen-associated or damage-associated molecular patterns, they trigger proteolytic cascades—inflammasome assemblies that activate inflammatory caspases such as caspase-1, caspase-4, caspase-5 and caspase-11, and, in apoptotic contexts, caspase-3 or granzyme-mediated cleavage. These enzymes cut the gasdermin at a flexible linker region, releasing the N-terminal fragment. Freed from its autoinhibitory partner, the fragment translocates to the plasma membrane, oligomerizes and inserts a large beta-barrel pore with an inner diameter on the order of 10 to 20 nanometers.

The consequences of pore formation are dramatic and rapid. Ions rush down their electrochemical gradients, water follows osmotically, the cell swells and bursts in the lytic mode of death known as pyroptosis. Before rupture, the pores permit the efflux of potassium and the release of mature interleukin-1beta and interleukin-18, alarmins such as high-mobility group box 1, and other inflammatory cargo that summon and shape the immune response. Pyroptosis is therefore not merely a demolition but a broadcast: the dying cell converts its own destruction into an alarm signal that recruits neutrophils, activates antigen-presenting cells and biases the adaptive immune system toward antiviral effector programs. This dual character—killing and alerting—makes the gasdermin system attractive for therapeutic exploitation, particularly against pathogens that thrive by suppressing or evading conventional immune pathways.

Viruses and gasdermins have long been adversaries in an evolutionary arms race. Many viruses encode inhibitors that block inflammasome sensors, sequester gasdermin fragments or interfere with caspase activation, reflecting the selective pressure that pyroptosis exerts on viral replication. Poxviruses, herpesviruses, influenza viruses and coronaviruses all deploy strategies to dampen inflammatory cell death. Conversely, host cells can route viral sensing signals toward gasdermin activation through multiple sensors, including ZBP1, which detects influenza A virus through recognition of Z-form nucleic acid, and AIM2 or IFI16, which sense foreign DNA. The observation that gasdermin activation can restrict viral replication even when interferon responses are disabled underscores the pathway’s value as a fail-safe. The Cell Research article situates the new engineering efforts within this biological context, arguing that the natural system’s potency has been limited chiefly by its lack of specificity and by viral countermeasures.

Here artificial intelligence changes the calculus. Modern structure-prediction systems such as AlphaFold2 and its successors have resolved the atomic architectures of gasdermin domains, their autoinhibited complexes and their membrane-inserted oligomeric pores, giving designers an accurate map of the conformational switch that governs activity. More consequentially, diffusion-based and language-model-based protein design tools now allow researchers to specify a desired function—a binding interface, a cleavage site, a regulatory logic module—and generate amino acid sequences predicted to fold into structures that fulfill it. Rather than screening natural variants or making incremental mutations, designers can compose gasdermin-based molecules from the ground up, fusing pore-forming domains to sensor modules that respond to molecular features found only in infected cells.

The design logic described in the article follows a gating principle. An engineered construct remains inert until it encounters a virus-specific cue: a viral protease that cleaves a designed linker, a viral RNA or DNA species bound by an engineered sensor domain, or a host-state marker such as a receptor induced by interferon signaling. Only when the gate opens is the gasdermin N-terminal domain released or reconfigured to oligomerize at the membrane. In principle, such constructs could discriminate infected from uninfected tissue with a fidelity that natural inflammasome pathways, which respond to broad danger signals, cannot achieve. The article emphasizes that computational modeling of pore geometry, oligomerization energetics and membrane interactions is essential at every step, because even small deviations in the N-terminal domain can abolish pore formation or, conversely, produce toxic nonspecific membrane binding.

Experimental validation of AI-designed gasdermins, as discussed in the piece, proceeds through iterative cycles in which predicted structures are tested in liposome leakage assays, cell-culture infection models and, ultimately, animal studies. Key metrics include the tightness of the off state, the sensitivity and specificity of the trigger response, the efficiency of membrane pore formation and the immunological consequences of pyroptotic lysis in vivo. The authors highlight that design failures are informative: constructs that leak activity reveal the energetic margins of autoinhibition, while constructs that fail to activate expose weaknesses in sensor-linker coupling. Each cycle feeds data back into the design pipeline, a workflow that has already accelerated progress in other classes of engineered proteins, including designed cytokines, antibody mimetics and switchable cell-death regulators.

The therapeutic implications extend across antiviral medicine and beyond. A programmable gasdermin could, in principle, be delivered as a gene therapy or mRNA therapeutic to tissues vulnerable to a specific pathogen, standing ready to eliminate infected cells before viral spread becomes established. Such an approach would be particularly valuable against emerging viruses for which vaccines and antivirals lag behind outbreak speed, and against chronic infections where viral evasion of immune clearance is the central obstacle. The same design principles could be adapted to oncology, since many tumors evade pyroptosis by silencing gasdermin expression or downregulating inflammasome components, and engineered constructs triggered by tumor-specific proteases or neoantigens could restore an inflammatory form of cancer-cell death that promotes antigen release and immune priming. The article notes that the concept of AI-guided cell-death engineering generalizes: gasdermins are one member of a broader class of pore-forming effectors, including the immune proteins MLKL in necroptosis and the complement membrane-attack complex, whose activity might similarly be placed under synthetic control.

Substantial challenges temper the enthusiasm. Uncontrolled pyroptosis is dangerous: excessive gasdermin activation drives cytokine storms, tissue damage and septic shock, as demonstrated by the lethal inflammation observed when gasdermin pores open unchecked during severe infections. Any engineered system must therefore incorporate fail-safes, such as dependence on multiple simultaneous triggers, dose-limiting delivery strategies and pharmacological off switches. Immune responses against designed protein sequences pose another obstacle, as does the difficulty of achieving tissue-restricted expression. Off-target activation in bystander cells, even at low frequency, could produce disproportionate inflammation given the potency of the pore-forming mechanism. The authors stress that computational predictions, however accurate, must be paired with rigorous empirical safety testing across diverse cell types and inflammatory contexts before clinical translation can be contemplated.

Nevertheless, the trajectory is clear. The gasdermin system, once understood only as a blunt instrument of innate defense, is becoming a designable platform. Artificial intelligence supplies the structural insight and generative capacity to reprogram its trigger logic, its target selectivity and even its pore properties, while the underlying biology supplies a death mechanism that is fast, inflammatory and inherently immunogenic—qualities well suited to antiviral defense. The Cell Research article frames this convergence as the beginning of a programmable immunology, in which the executioners of cell death are no longer merely triggered by infection but are deliberately built to seek it out. If the engineering challenges of specificity, control and delivery can be met, AI-guided gasdermins may transform the treatment of viral disease from a defensive struggle into a precise, pre-emptive campaign against the cells that harbor the enemy.

Subject of Research: AI-guided engineering of gasdermin proteins to induce pyroptotic death of virus-infected cells

Article Title: Programmed to kill: AI-guided gasdermins eliminate virus-infected cells

Article References: Betrancourt, A., & Broz, P. (2026). Programmed to kill: AI-guided gasdermins eliminate virus-infected cells. Cell Research. https://doi.org/10.1038/s41422-026-01292-y

Image Credits: AI Generated

DOI: 10.1038/s41422-026-01292-y

Keywords: gasdermin, pyroptosis, AI protein design, innate immunity, virus-infected cells, inflammasome, cell death, antiviral therapy, protein engineering, pore-forming proteins, Cell Research, immunotherapy